BILATERAL ORBITAL AND FLOOR OF THE MOUTH SWELLING: A CASE REPORT OF IgG4-RELATED DISEASE

IgG4-related disease (IgG4-RD) is characterized by IgG4-positive plasma cell infiltration and fibrosis mostly in the pancreas, bile ducts, salivary glands, and orbits. A 34-year-old woman with a history of chronic rhinitis presented with bilateral asymptomatic orbital swelling of 7 years’ duration....

Full description

Saved in:
Bibliographic Details
Published in:Oral surgery, oral medicine, oral pathology and oral radiology Vol. 130; no. 3; pp. e117 - e118
Main Authors: MONTE, CAROLINA MENDES FRUSCA DO, CORTEZZI, ELLEN BRILHANTE DE ALBUQUERQUE, CANEDO, NATHALIE HENRIQUES SILVA, PIRES, ANDREA RODRIGUES CORDOVIL, ANDRADE, BRUNO AUGUSTO BENEVENUTO DE, ROMAÑACH, MÁRIO JOSÉ, AGOSTINI, MICHELLE
Format: Journal Article
Language:English
Published: Elsevier Inc 01-09-2020
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IgG4-related disease (IgG4-RD) is characterized by IgG4-positive plasma cell infiltration and fibrosis mostly in the pancreas, bile ducts, salivary glands, and orbits. A 34-year-old woman with a history of chronic rhinitis presented with bilateral asymptomatic orbital swelling of 7 years’ duration. Extra-oral examination revealed bilateral palpebral swelling and dacryoadenitis, whereas bilateral normal-colored swelling of the floor of the mouth was detected intra-orally. Serologic tests for IgG4 showed an elevated concentration of 698 mg/dL, and an incisional oral biopsy was performed. Histopathologic analysis revealed minor salivary glands with marked infiltration of lymphocytes, histiocytes, and plasma cells, with occasional lymphoid follicles. By immunohistochemistry, the histiocytes were positive for CD163, and IgG4 was positive in more than 50 plasma cells per high-power field. The final diagnosis was IgG4-RD. The patient was referred for treatment in a rheumatology service. Systemic involvement was not detected, and there was an improvement of orbital and oral lesions after oral corticosteroid therapy.
ISSN:2212-4403
2212-4411
DOI:10.1016/j.oooo.2020.04.038